References
- Waitzman NJ, Scheffler RM, Romano PS. The costs of birth defects: estimates of the value of prevention. University Press of America Inc; New York, London, Lanham: 1996
- Gold MR, Siegel JE, Russell LB, Weinstein MC. Cost-Effectiveness in Health and Medicine. Oxford: Oxford University Press; New York: 1996
- Kelly AE, Haddix AC, Scanlon KS, et al. Cost-effectiveness of strategies to prevent neural tube defects. In: Siegel JE, Russell LB, Weinstein MC, Gold MR, editors. Cost-Effectiveness in Health and Medicine. Oxford: Oxford University Press; New York: 1996. pp. 312-49
- World Health Organizaton. The Global Burden of Disease – 2004 Update. Available from: www.who.int/healthinfo/global_burden_disease/2004_report_update/en/
- National Institute for Health and Care Excellence. Guide to the methods of technology appraisal 2013. Available from: http://publications.nice.org.uk/pmg9
- Basu A, Meltzer D. Implications of spillover effects within the family for medical cost-effectiveness analysis. J Health Econ 2005;24:751-73
- Basu A, Dale W, Elstein A, Meltzer D. A time tradeoff method for eliciting partner’s quality of life due to patient’s health states in prostate cancer. Med Decis Making 2010;30:355-65
- Prosser LA, Lamarand K, Gebremariam A, Wittenberg E. Measuring family HRQoL spillover effects using direct health utility assessment. Med Decis Making 2014. [Epub ahead of print]
- Neumann PJ, Kuntz KM, Leon J, et al. Health utilities in Alzheimer’s disease: a cross-sectional study of patients and caregivers. Med Care 1999;37:27-32
- Bell CM, Araki SS, Neumann PJ. The association between caregiver burden and caregiver health-related quality of life in Alzheimer disease. Alzheimer Dis Assoc Disord 2001;15:129-36
- Tilford JM, Grosse SD, Robbins JM, et al. Health state preference scores of children with spina bifida and their caregivers. Qual Life Res 2005;14:1087-98
- Payakachat N, Tilford JM, Brouwer WB, et al. Measuring health and well-being effects in family caregivers of children with craniofacial malformations. Qual Life Res 2011;20:1487-95
- Smith-Olinde L, Grosse SD, Olinde F, et al. Health state preference scores for children with permanent childhood hearing loss: a comparative analysis of the QWB and HUI3. Qual Life Res 2008;17:943-53
- Tilford JM, Kuhlthau KA, Payakachat N, et al. Health utilities and caregiver spillover effects associated with sleep problems in children with autism spectrum disorders. Paper presented at the International Society for Quality of Life Research annual meeting. USA; 2013
- Knapp M, King D, Romeo R, et al. Cost effectiveness of a manual based coping strategy programme in promoting the mental health of family careers of people with dementia (the START (STrAtegies for RelaTives) study): a pragmatic randomised controlled trial. BMJ 2013;347:f6342
- Romeo R, Knapp M, Hellier J, et al. Cost-effectiveness analyses for mirtazapine and sertraline in dementia: randomised controlled trial. Br J Psychiatry 2013;202:121-8
- Brouwer WB, Koopmanschap MA, Rutten FF. Productivity costs measurement through quality of life? A response to the recommendation of the Washington Panel. Health Econ 1997;6:253-9
- Brouwer WB, Grootenboer S, Sendi P. The incorporation of income and leisure in health state valuations when the measure is silent: an empirical inquiry into the sound of silence. Med Decis Making 2009;29:503-12
- Al-Janabi H, Flynn TN, Coast J. QALYs and Carers. Pharmacoeconomics 2011;29(12):1015-23
- Bobinac A, van Exel NJ, Rutten FF, Brouwer WB. Caring for and caring about: disentangling the caregiver effect and the family effect. J Health Econ 2010;29:549-56
- Bobinac A, van Exel NJ, Rutten FF, Brouwer WB. Health effects in significant others: separating family and care-giving effects. Med Decis Making 2011;31:292-8
- Wittenberg E, Prosser LA. Disutility of illness for caregivers and families: a systematic review of the literature. Pharmacoeconomics 2013;31:489-500